Advanced Prostate Cancer
5,760 members5,465 posts

Trials NCT 03338790 or NCT02897375 Decided on NCT 03338790 trial

Just an update decided to do NCT 03338790 with Nivolumab and Rucaparib, study closer to me, less travel and parp inhibitor may help . Anyone on either of this trials NCT 03338790 (An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CheckMate 9KD))

or NCT02897375 (Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors)


2 Replies

I just got accepted to the CheckMate 9KD trial at Duke. I am in the nivolumab/rucaparib arm. Any info on how you're doing would be appreciated: results, side effects, etc. Thank you very much.


I dropped out after 3 months due to complications, (small bowel issues ). I saw no drop in psa or size of mets in nodes, but nodes did not enlarge either.

Good luck


You may also like...